A combination of iza-bren (BL-B01D1), a novel bispecific antibody-drug conjugate (ADC), with osimertinib demonstrated a 100% objective response rate (ORR) in patients with first-line EGFR-mutated ...

A new analysis from the COMPEL trial shows that patients with EGFR-mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) who experienced non-central nervous system (CNS) progression on ...

University of Leicester scientists have identified two extraordinary new fossils - tiny prehistoric flying reptiles, ...

A new study presented at the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer (WCLC) validates the use of Sybil, a deep learning artificial intelligence ...

A novel antibody-drug conjugate (ADC), iza-bren (BL-B01D1), demonstrated encouraging safety and efficacy results in previously treated patients with EGFR-mutated non-small cell lung cancer (NSCLC), ...

An analysis from the Phase 3 CheckMate 77T trial confirms that perioperative nivolumab does not compromise health-related quality of life (HRQoL) in patients with resectable non-small cell lung cancer ...

Trial suggests using bedside scans instead of traditional stethoscopes shortens hospitalization and lowers costs.

Results from the FigHTN Phase 2 clinical trial showed baxdrostat, a new medication that inhibits the production of the hormone aldosterone, lowered systolic blood pressure by about 5% when added to ...

A study has found that adolescents become highly motivated to seek rewards after just a few hours of social isolation. This ...

Hudson, MD, FASIA, of Kessler Foundation was awarded the prestigious James J. Peters Distinguished Service Award at the 2025 ...

This study demonstrated that environment influences autism-like behaviours in genetically predisposed zebrafish. By altering ...

A long-term study spanning more than 50 years illustrates how the beavers that have returned to the Evo region in southern ...